Search research articles
Contact Us
Filters
Showing results (181-190 of 271) with videos related to
Page
of 28
Sort By:
Cancer Research
|
September 28, 2016
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
Andriy Marusyk, Doris P Tabassum, Michalina Janiszewska, et al.
Science (New York, N.Y.)
|
August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivity
Gopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Nature Communications
|
January 6, 2022
Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling
Carla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Plos Genetics
|
September 26, 2007
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer
Kornel E Schuebel, Wei Chen, Leslie Cope, et al.
The New England Journal of Medicine
|
November 20, 2014
Genetic basis for clinical response to CTLA-4 blockade in melanoma
Alexandra Snyder, Vladimir Makarov, Taha Merghoub, et al.
Brain : a Journal of Neurology
|
March 30, 2016
Corticosteroids compromise survival in glioblastoma
Kenneth L Pitter, Ilaria Tamagno, Kristina Alikhanyan, et al.
Blood
|
November 8, 2021
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders
Simona Pagliuca, Carmelo Gurnari, Hassan Awada, et al.
Nature
|
February 21, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan, Daniel Rohle, Anuj Goenka, et al.
Science Advances
|
June 22, 2022
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma
Ian Ganly, Eric Minwei Liu, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 271) with videos related to
Sort By:
Page
of 28
Cancer Research
|
September 28, 2016
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
Andriy Marusyk, Doris P Tabassum, Michalina Janiszewska, et al.
Science (New York, N.Y.)
|
August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivity
Gopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Nature Communications
|
January 6, 2022
Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling
Carla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Plos Genetics
|
September 26, 2007
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer
Kornel E Schuebel, Wei Chen, Leslie Cope, et al.
The New England Journal of Medicine
|
November 20, 2014
Genetic basis for clinical response to CTLA-4 blockade in melanoma
Alexandra Snyder, Vladimir Makarov, Taha Merghoub, et al.
Brain : a Journal of Neurology
|
March 30, 2016
Corticosteroids compromise survival in glioblastoma
Kenneth L Pitter, Ilaria Tamagno, Kristina Alikhanyan, et al.
Blood
|
November 8, 2021
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders
Simona Pagliuca, Carmelo Gurnari, Hassan Awada, et al.
Nature
|
February 21, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan, Daniel Rohle, Anuj Goenka, et al.
Science Advances
|
June 22, 2022
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma
Ian Ganly, Eric Minwei Liu, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, et al.
Page
of 28